Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 481 AL 495

Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer's disease: the challenges ahead

Lozupone M, Dibello V, Resta E, Sardone R, Castellana F, Zupo R, Lampignano L, Bortone I, Mollica A, Berardino G, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Panza F.

Expert Rev Neurother. 2025 Jun;25(6):649-659. doi: 10.1080/14737175.2025.2500752. Epub 2025 May 5.

Alzheimer's disease and age-related macular degeneration: Shared and distinct immune mechanisms

Butovsky O, Rosenzweig N.

Immunity. 2025 May 13;58(5):1120-1139. doi: 10.1016/j.immuni.2025.04.013. Epub 2025 May 4.

[Therapeutic potential of ion channel modulation in Alzheimer's disease]

Huang B, Yang CM, Lu ZC, Tang LN, Mo SL, Jian CD, Shang JW.

Sheng Li Xue Bao. 2025 Apr 25;77(2):327-344. doi: 10.13294/j.aps.2025.0029.

Advancements in Stem Cell Research for Effective Therapies Against Alzheimer's Disease: Current Investigation and Future Insight

Gupta A, Ghosh A, Sharma N, Gorain B.

Mol Neurobiol. 2025 Nov;62(11):14560-14584. doi: 10.1007/s12035-025-05003-3. Epub 2025 May 6.

[Research progress of treating Alzheimer's disease with traditional Chinese medicine]

Liu X, Zhang RB, Li CX, Li WL.

Zhongguo Zhong Yao Za Zhi. 2025 Mar;50(5):1146-1154. doi: 10.19540/j.cnki.cjcmm.20241111.601.

Let-7 Family as a Mediator of Exercise on Alzheimer's Disease

Ke S, Liu Z, Wan Y.

Cell Mol Neurobiol. 2025 May 19;45(1):43. doi: 10.1007/s10571-025-01559-9.

Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and creative modification techniques

Meng X, Gong Y, Xiao F, Cao Z, Zhuang Z, Yi X, Wang J, Feng R, Gong C, Ni P.

J Alzheimers Dis. 2025 Jul;106(2):410-426. doi: 10.1177/13872877251344188. Epub 2025 Jul 1.

Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC

Frederiksen KS, Boada M, Dubois B, Engelborghs S, Frisoni GB, Georges J, Hort J, Jönsson L, Kramberger MG, Ousset PJ, Scarmeas N, Schmidt R, Schott JM, Spiro L, Waldemar G, Winblad B, Jessen F, Frölich L.

Alzheimers Res Ther. 2025 May 24;17(1):116. doi: 10.1186/s13195-025-01766-y.

[Prospects for treating Alzheimer's disease]

Vakhnina NV, Novikov DK, Vekhova KA, Zhuk AM, Klimanovich DL, Isaikin AI, Zakharov VV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(4. Vyp. 2):54-60. doi: 10.17116/jnevro202512504254.

Genetics and Epigenetics of Alzheimer's Disease: Understanding Pathogenesis and Exploring Therapeutic Potential

Tiwari P, Dwivedi R, Kaushik M, Tripathi M, Dada R.

J Mol Neurosci. 2025 May 30;75(2):72. doi: 10.1007/s12031-025-02363-2.

The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease and future strategies for targeted therapy

Li X, Wu Z, Si X, Li J, Wu G, Wang M.

Eur J Med Res. 2025 May 31;30(1):434. doi: 10.1186/s40001-025-02699-w.

Targeting Alzheimer's disease pathology: influence of nano-based drug delivery systems loaded with a combination of herbal and synthetic drugs

Mumtaz, Unnithan D, Bano A, Chauhan APS, Ali J, Khan MA.

Expert Opin Drug Deliv. 2025 Aug;22(8):1155-1170. doi: 10.1080/17425247.2025.2513440. Epub 2025 Jun 18.

Large language models for Alzheimer's disease drug discovery

Alkam T, Tarshizi E, Van Benschoten AH.

J Alzheimers Dis. 2025 Aug;106(3):799-822. doi: 10.1177/13872877251346890. Epub 2025 Jun 2.

Thioredoxin-interacting protein: an emerging target for Alzheimer's disease

Patil R, Parab SB, Bhatt LK.

Eur J Pharmacol. 2025 Sep 5;1002:177806. doi: 10.1016/j.ejphar.2025.177806. Epub 2025 Jun 4.

Biomaterials in Alzheimer's Disease: An Anti-Neuroinflammatory Perspective

Huang N, Huang W, Wang M, Shi J, Luo Y, Huang J.

Adv Healthc Mater. 2025 Jul;14(19):e2500498. doi: 10.1002/adhm.202500498. Epub 2025 Jun 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias